Elanco Animal Health (ELAN) Total Liabilities (2017 - 2026)
Elanco Animal Health (ELAN) posted Total Liabilities of $6.7 billion for Q1 2026, down 1.31% sequentially from $6.8 billion in Q4 2025, and up 2.03% YoY from $6.6 billion in Q1 2025.
Elanco Animal Health (ELAN) Total Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Total Liabilities for 10 years, with the latest figure at $6.7 billion in Q1 2026.
- Quarterly Total Liabilities rose 2.03% year-over-year to $6.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 billion (up 2.03% YoY) and the FY2025 annual result came in at $6.8 billion, up 4.5% from the prior year.
- Total Liabilities fell to $6.7 billion in Q1 2026 per ELAN's latest filing, from $6.8 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $8.6 billion in Q1 2022 and troughed at $49.0 million in Q2 2022.
- A 5-year average of $7.1 billion and a median of $7.8 billion in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities slumped 99.45% in 2022, then soared 16993.88% in 2023.
- Over 5 years, Total Liabilities stood at $8.2 billion in 2022, then fell by 0.77% to $8.1 billion in 2023, then declined by 19.92% to $6.5 billion in 2024, then grew by 4.5% to $6.8 billion in 2025, then decreased by 1.31% to $6.7 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $6.7 billion, $6.8 billion, and $6.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 2.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.97 Bn |
| Mar 31, 2026 | 6.72 Bn |
| Dec 31, 2025 | 6.81 Bn |
| Sep 30, 2025 | 6.80 Bn |
| Jun 30, 2025 | 6.97 Bn |
| Mar 31, 2025 | 6.59 Bn |
| Dec 31, 2024 | 6.52 Bn |
| Sep 30, 2024 | 6.76 Bn |
| Jun 30, 2024 | 7.82 Bn |
| Mar 31, 2024 | 7.96 Bn |
| Dec 31, 2023 | 8.14 Bn |
| Sep 30, 2023 | 8.21 Bn |
| Jun 30, 2023 | 8.38 Bn |
| Mar 31, 2023 | 8.29 Bn |
| Dec 31, 2022 | 8.20 Bn |
| Sep 30, 2022 | 8.20 Bn |
| Jun 30, 2022 | 49.00 Mn |
| Mar 31, 2022 | 8.64 Bn |
| Dec 31, 2021 | 8.97 Bn |
| Sep 30, 2021 | 8.88 Bn |